Close Menu

NEW YORK (GenomeWeb) – Neural cells derived from human induced pluripotent stem cells can give insight into what drugs might treat schizophrenia, according to a new study.

Current drugs to treat people with schizophrenia are only effective in a portion of patients, as about two-thirds either don't respond to treatment or only partially respond. However, a lack of models has limited the ability to develop new therapies, the authors of the new study said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.